Comparative study of hemostasis and cytokine production in experimental Dengue virus infection

Voprosy Virusologii

Volumn 52, Issue 2, 2007, Pages 32-36

  Bukin, Ye K ^a   Otrashevskaya, Ye V ^a   Vorobyeva, M S ^a   Ignatyev, G M ^a  

^a NONE

Author keywords

Cytokines; Dengue virus; Experimental infection; Mice

Indexed keywords

DENGUE VIRUS; MURINAE; MUS;

EID: 34248231317     PISSN: 05074088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Russian source
2. Russian source
3. Atrasheuskaya A., Petzelbauer P., Fredeking T. M., Ignatyev G. Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection // FEMS Immunol. Med. Microbiol. - 2003. - Vol. 35, N 1. - P. 33-42.
4. Bethell D. B., Flobbe K., Cao X. T. et al. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever // J. Infect. Dis. - 1998. - Vol. 177, N 3. - P. 778-782.
5. Burke T. Dengue haemorrhagic fever: a pathological study // Trans. Roy. Soc. Trop. Med. Hyg. - 1968. - Vol. 62, N 5. P. 682-692.
6. Chaturvedi U. C., Raghupathy R., Pacsa A. S. et al. Shift from a Th1-type response to Th2-type in dengue haemorrhagic fever // Curr. Sci. - 1999. - Vol. 76. - P. 63-69.
7. Chaturvedi U. C., Agarwal R., Elbishbishi E. A., Mustafa A. S. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis // FEMS Immunol. Med. Microbiol. - 2000. Vol. 28, N 3. - P. 183-188.
8. Chin C. K., Kang B. H., Liew B. K. et al. Protocol for out-patient management of dengue illness in young adults // J. Trop. Med. Hyg. - 1993. - Vol. 96, N 4. - P. 259-263.
9. Dewi B. E., Takasaki T., Kurane I. In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection // J. Virol. Meth. - 2004. Vol. 121, N 2. - P. 171-180.
10. Fattori E., Cappelletti M., Costa P. et al. Defective inflammatory response in interleukin 6-deficient mice // J. Exp. Med. - 1994. - Vol. 180. - P. 1243-1250.
11. Green S., Vaughn D. W., Kalayanarooj S. et al. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity //. J. Med. Virol. - 1999. - Vol. 59, N 3. - P. 329-334.
12. Gruol D. L., Nelson T. E. Physiological and pathological roles of interleukin-6 in the central nervous system // Mol. Neurobiol. - 1997. - Vol. 15. - P. 307-309.
13. Gubler D. J. The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle? // Comp. Immunol. Microbiol. Infect. Dis. - 2004. - Vol. 27, N 5. - P. 319-330.
14. Henchal E. A., Putnak J. R. The dengue viruses // Clin. Microbiol. Rev. - 1990. - Vol. 3, N 4. - P. 376-396.
15. Igaz P., Horvath A., Horvath B. et al. Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production // Immunol. Lett. - 2000. - Vol. 71, N 3. - P. 143-148.
16. Juffrie M., Meer G. M., Hack C. E. et al. Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2 // Am. J. Trop. Med. Hyg. - 2001. - Vol. 65, N 1. - P. 70-75.
17. Lanciotti R. S., Calisher C. H., Gubler D. J. et al. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction // J. Clin. Microbiol. - 1992. - Vol. 30, N 3. - P. 545-551.
18. Lei H. Y., Yeh T. M., Liu H. S. et al. Immunopathogenesis of dengue virus infection // J. Biomed. Sci. - 2001. - Vol. 8, N 5. - P. 377-388.
19. Libraty D. H., Pichyangkul S., Ajariyakhajorn C. et al. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis // J. Virol. - 2001. - Vol. 75, N 8. - P. 3501-3508.
20. Malavige G. N., Fernando S., Fernando D. J., Seneviratne S. L. Dengue viral infections // Postgrad. Med. J. - 2004. - Vol. 80, N 948. - P. 588-601.
21. Mitrakul C. Bleeding problem in dengue haemorrhagic fever: platelets and coagulation changes // South. Asian J. Trop. Med. Publ. Hlth. - 1987. - Vol. 18, N 3. - P. 407-412.
22. Nguyen T. H., Lei H. Y., Nguyen T. L. et al. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles // J. Infect. Dis. - 2004. - Vol. 189, N 2. - P. 221-232.
23. Pacsa A. S., Agarwal R., Elbishbrishi E. A. et al. Role of interleukin-12 in patients with dengue hemorrhagic fever // FEMS Immunol. Med. Microbiol. - 2000. - Vol. 28, N 2. -P. 151-155.
24. Rothman A. L., Ennis F. A. Immunopathogenesis of dengue hemorrhagic fever // Virology. - 1999. - Vol. 257, N 1. - P. 1-6.
25. Schnittler H. J., Feldmann H. Viral hemorrhagic fever - a vascular disease? // Thromb. Haemost. - 2003. - Vol. 89, N 6. - P. 967-972.
26. Sosman J. A., Verma A., Moss S. et al. Interleukin 10-induced thrombocytopenia in normal healthy adult volunteers: evidence for decreased platelet production // Br. J. Haematol. - 2000. - Vol. 111, N 1. - P. 104-111.
27. WHO. Dengue and Dengue Haemorrhagic Fever. Fact sheet N 117. - Geneva, 2002.
28. Xing Z., Gauldie J., Cox G. et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses // J. Clin. Invest. - 1998. - Vol. 101, N 2. - P. 311-320.